SE9800806L - Användning av kollagenas - Google Patents

Användning av kollagenas

Info

Publication number
SE9800806L
SE9800806L SE9800806A SE9800806A SE9800806L SE 9800806 L SE9800806 L SE 9800806L SE 9800806 A SE9800806 A SE 9800806A SE 9800806 A SE9800806 A SE 9800806A SE 9800806 L SE9800806 L SE 9800806L
Authority
SE
Sweden
Prior art keywords
collagenase
disease
hand
dupuytren
ruptured
Prior art date
Application number
SE9800806A
Other languages
Unknown language ( )
English (en)
Other versions
SE9800806D0 (sv
SE522723C2 (sv
Inventor
Thomas L Wegman
Original Assignee
Advance Biofactures Curacao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Curacao filed Critical Advance Biofactures Curacao
Publication of SE9800806D0 publication Critical patent/SE9800806D0/sv
Publication of SE9800806L publication Critical patent/SE9800806L/sv
Publication of SE522723C2 publication Critical patent/SE522723C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
SE9800806A 1997-03-27 1998-03-12 Användning av kollagenas vid behandling av Dupuytrens sjukdom SE522723C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/826,015 US6086872A (en) 1997-03-27 1997-03-27 Amelioration of dupuytren's disease

Publications (3)

Publication Number Publication Date
SE9800806D0 SE9800806D0 (sv) 1998-03-12
SE9800806L true SE9800806L (sv) 1998-09-28
SE522723C2 SE522723C2 (sv) 2004-03-02

Family

ID=25245473

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9800806A SE522723C2 (sv) 1997-03-27 1998-03-12 Användning av kollagenas vid behandling av Dupuytrens sjukdom

Country Status (8)

Country Link
US (2) US6086872A (sv)
AU (1) AU733208B2 (sv)
DE (1) DE19813748A1 (sv)
DK (1) DK177324B1 (sv)
FR (2) FR2772273B1 (sv)
GB (1) GB2323530B (sv)
NO (1) NO981388L (sv)
SE (1) SE522723C2 (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
GB0306165D0 (en) * 2003-03-18 2003-04-23 Delta G Ltd Medical treatment
CN101107006B (zh) * 2005-01-21 2013-09-11 纽约州立大学研究基金会 治疗黏连性关节囊炎的方法
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2008100833A2 (en) * 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
EP2403523A1 (en) * 2009-03-06 2012-01-11 Halozyme, Inc. Temperature sensitive mutants of matrix metalloprotease 1 und uses thereof
WO2010111525A2 (en) 2009-03-25 2010-09-30 Agee, John, M., Trustee Of The John M. Agee Trust Of August 15, 1996 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
AU2011322482B2 (en) * 2010-10-30 2017-03-23 Oxford University Innovation Limited Treatment for Dupuytren's disease
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
WO2013011514A1 (en) 2011-07-20 2013-01-24 Mediwound Ltd. Proteolytic extract from bromelain for the treatment of connective tissue disorders
GB201119089D0 (en) 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
PT2802652T (pt) 2012-01-12 2019-09-10 Endo Global Ventures Enzimas de clostridium histolyticum
US20150079069A1 (en) * 2012-04-30 2015-03-19 Elastomics Ab Methods for modification of tissues
US9636385B2 (en) 2012-10-24 2017-05-02 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
US20150196625A9 (en) 2013-01-07 2015-07-16 Rudolph D. Paladini Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
EP3834840B8 (en) 2013-03-15 2025-09-17 Endo Biologics Limited Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
EP4591945A3 (en) 2017-03-01 2026-04-15 Endo Operations Limited Apparatus and method for assessing and treating cellulite
JP7227918B2 (ja) 2017-03-28 2023-02-22 エンド ベンチャーズ リミテッド コラゲナーゼ産生の改良された方法
US11872267B2 (en) 2019-10-15 2024-01-16 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5589171A (en) * 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase

Also Published As

Publication number Publication date
GB9805050D0 (en) 1998-05-06
FR11C0033I1 (sv) 2011-09-23
AU5966198A (en) 1998-10-01
FR11C0033I2 (fr) 2012-03-16
SE9800806D0 (sv) 1998-03-12
DK177324B1 (da) 2013-01-07
USRE39941E1 (en) 2007-12-18
SE522723C2 (sv) 2004-03-02
AU733208B2 (en) 2001-05-10
DK40398A (da) 1998-09-28
GB2323530A (en) 1998-09-30
DE19813748A1 (de) 1998-10-01
NO981388D0 (no) 1998-03-26
GB2323530B (en) 2001-10-10
FR2772273A1 (fr) 1999-06-18
FR2772273B1 (fr) 2003-04-25
NO981388L (no) 1998-09-28
US6086872A (en) 2000-07-11

Similar Documents

Publication Publication Date Title
SE9800806L (sv) Användning av kollagenas
ID23600A (id) Turunan tiazolidin dan oksazolidin, pembuatan dan penggunaannya untuk pengobatan (pecahan dari p-950453)
DE59814072D1 (de) Verwendung von Agonisten des zentralen Cannabinoid-Rezeptors CB1
EP1018987A4 (en) NEO-CARTILAGE AND ITS METHODS OF USE
BR9306683A (pt) Adesivo proteináceo curado com aldeído
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
ID16862A (id) Komposisi-komposisi elastomer dan metoda-metoda pembuatannya
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
ATE223431T1 (de) Derivate von dolastatin, dreen herstellung un verwendung
NO169657C (no) Fremgangsmaate for fremstilling av svovel-olefin-vulkaniseringsmiddel for naturlig og syntetisk gummi og anvendelse av dette
IT1285770B1 (it) Composti corticoidei
DE69625857D1 (de) Siliconderivate, ihre Herstellung und Verwendung
ATE113207T1 (de) Benzamid gegen kognitive erkrankungen.
DE69521595D1 (de) Optisch-aktives Benzothiepin-Derivate, ihre Herstellung und Verwendung
ID17199A (id) Mikro-organisme pengurai hidrokarbon yang mengandung halogen dan pemakaiannya
DE69532106D1 (de) Maltose Phospharylase, Trehalose Phophorylase, Plesiomonasstamm, und Herstellung von Trehalose
DK1044014T3 (da) Middel til behandling af allergiske eller hypersensitivitets-tilstande
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
DE69421743D1 (de) Silikongummi-Zusammensetzungen, Herstellung und Verwendung
DE59606806D1 (de) Polymerholz-formkörper, ihre herstellung und verwendung
NO955258D0 (no) Medisinsk anvendelse av enzymer
ATE94624T1 (de) Elastische, hydraulisch gedaempfte buchse mit radialer elastizitaet und entkoppelung der steifigkeiten.
DE69304871D1 (de) Dicyanatpräpolymere, ihre Verwendung und Herstellung
ATE198192T1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
ES2152315T3 (es) Xamoneline tartrato.

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: PRODUCT NAME: KOLLAGENAS CLOSTRIDIUM HISTOLYTICUM; REG. NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 1190022-2.L

SPCG Supplementary protection certificate granted

Free format text: PRODUCT NAME: KOLLAGENAS CLOSTRIDIUM HISTOLYTICUM; REG. NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 1190022-2

Expiry date: 20180313

Extension date: 20230312

NUG Patent has lapsed